Page last updated: 2024-09-03

1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and bicuculline

1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane has been researched along with bicuculline in 1 studies

Compound Research Comparison

Studies
(1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane)
Trials
(1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane)
Recent Studies (post-2010)
(1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane)
Studies
(bicuculline)
Trials
(bicuculline)
Recent Studies (post-2010) (bicuculline)
40056,2533759

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albin, RL; Kume, A1

Other Studies

1 other study(ies) available for 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and bicuculline

ArticleYear
Quantitative autoradiography of 4'-ethynyl-4-n-[2,3-3H2]propylbicycloorthobenzoate binding to the GABAA receptor complex.
    European journal of pharmacology, 1994, Sep-22, Volume: 263, Issue:1-2

    Topics: Adult; Aged; Aged, 80 and over; Animals; Autoradiography; Bicuculline; Binding Sites; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; GABA Agonists; Humans; Isonicotinic Acids; Male; Middle Aged; Picrotoxin; Rats; Rats, Sprague-Dawley; Receptors, GABA; Species Specificity

1994